Cargando…
Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk?
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486810/ https://www.ncbi.nlm.nih.gov/pubmed/36147336 http://dx.doi.org/10.3389/fphar.2022.999301 |
| _version_ | 1784792361056862208 |
|---|---|
| author | do Rosário Souza, Mariana Silva da Paz, Wandklebson dos Santos Sales, Vinícius Barbosa Hilario de Jesus, Gleidson Felipe dos Santos Tavares, Débora Almeida Lima, Shirley V. M. Lopes Sousa, Álvaro Francisco Vieira de Melo, Enaldo Feliciano do Carmo, Rodrigo Freire de Souza, Carlos Dornels Bezerra-Santos, Márcio |
| author_facet | do Rosário Souza, Mariana Silva da Paz, Wandklebson dos Santos Sales, Vinícius Barbosa Hilario de Jesus, Gleidson Felipe dos Santos Tavares, Débora Almeida Lima, Shirley V. M. Lopes Sousa, Álvaro Francisco Vieira de Melo, Enaldo Feliciano do Carmo, Rodrigo Freire de Souza, Carlos Dornels Bezerra-Santos, Márcio |
| author_sort | do Rosário Souza, Mariana |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9486810 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94868102022-09-21 Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk? do Rosário Souza, Mariana Silva da Paz, Wandklebson dos Santos Sales, Vinícius Barbosa Hilario de Jesus, Gleidson Felipe dos Santos Tavares, Débora Almeida Lima, Shirley V. M. Lopes Sousa, Álvaro Francisco Vieira de Melo, Enaldo Feliciano do Carmo, Rodrigo Freire de Souza, Carlos Dornels Bezerra-Santos, Márcio Front Pharmacol Pharmacology Frontiers Media S.A. 2022-09-06 /pmc/articles/PMC9486810/ /pubmed/36147336 http://dx.doi.org/10.3389/fphar.2022.999301 Text en Copyright © 2022 Rosário Souza, Silva da Paz, dos Santos Sales, Hilario de Jesus, dos Santos Tavares, Almeida Lima, Lopes Sousa, Vieira de Melo, Feliciano do Carmo, Freire de Souza and Bezerra-Santos. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology do Rosário Souza, Mariana Silva da Paz, Wandklebson dos Santos Sales, Vinícius Barbosa Hilario de Jesus, Gleidson Felipe dos Santos Tavares, Débora Almeida Lima, Shirley V. M. Lopes Sousa, Álvaro Francisco Vieira de Melo, Enaldo Feliciano do Carmo, Rodrigo Freire de Souza, Carlos Dornels Bezerra-Santos, Márcio Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk? |
| title | Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk? |
| title_full | Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk? |
| title_fullStr | Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk? |
| title_full_unstemmed | Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk? |
| title_short | Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk? |
| title_sort | corrigendum: impact of the covid-19 pandemic on the diagnosis of tuberculosis in brazil: is the who end tb strategy at risk? |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486810/ https://www.ncbi.nlm.nih.gov/pubmed/36147336 http://dx.doi.org/10.3389/fphar.2022.999301 |
| work_keys_str_mv | AT dorosariosouzamariana corrigendumimpactofthecovid19pandemiconthediagnosisoftuberculosisinbrazilisthewhoendtbstrategyatrisk AT silvadapazwandklebson corrigendumimpactofthecovid19pandemiconthediagnosisoftuberculosisinbrazilisthewhoendtbstrategyatrisk AT dossantossalesviniciusbarbosa corrigendumimpactofthecovid19pandemiconthediagnosisoftuberculosisinbrazilisthewhoendtbstrategyatrisk AT hilariodejesusgleidsonfelipe corrigendumimpactofthecovid19pandemiconthediagnosisoftuberculosisinbrazilisthewhoendtbstrategyatrisk AT dossantostavaresdebora corrigendumimpactofthecovid19pandemiconthediagnosisoftuberculosisinbrazilisthewhoendtbstrategyatrisk AT almeidalimashirleyvm corrigendumimpactofthecovid19pandemiconthediagnosisoftuberculosisinbrazilisthewhoendtbstrategyatrisk AT lopessousaalvarofrancisco corrigendumimpactofthecovid19pandemiconthediagnosisoftuberculosisinbrazilisthewhoendtbstrategyatrisk AT vieirademeloenaldo corrigendumimpactofthecovid19pandemiconthediagnosisoftuberculosisinbrazilisthewhoendtbstrategyatrisk AT felicianodocarmorodrigo corrigendumimpactofthecovid19pandemiconthediagnosisoftuberculosisinbrazilisthewhoendtbstrategyatrisk AT freiredesouzacarlosdornels corrigendumimpactofthecovid19pandemiconthediagnosisoftuberculosisinbrazilisthewhoendtbstrategyatrisk AT bezerrasantosmarcio corrigendumimpactofthecovid19pandemiconthediagnosisoftuberculosisinbrazilisthewhoendtbstrategyatrisk |